Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Valeant Pharmaceuticals
Latest Articles
Premium
Activists Turn Out a Strong First Quarter
Stephen Taub
Aggressive Pharma Ads Yield Results — and Complaints
Khadijah M Silver
Daily Agenda: Clinton Secures Nomination. What’s Next for the Markets?
Andrew Barber
Daily Agenda: The Week Ahead, October 26 – 31, 2015
Andrew Barber
Drug Wars: The Battle to Put a Lid on Rising Prices
Khadijah M Silver
Premium
Eton Park Surges on Broad-Based Gains
Stephen Taub
Hedge Fund Manager Kyle Bass Declares War on Drug Prices
Jess Delaney
Premium
Hound Partners Leads Tiger Pack in First Quarter
Stephen Taub
Premium
Jana Partners Absorbs Another Monthly Loss
Stephen Taub
Premium
Jana Records a Slightly Down March as Volatilty Hits
Stephen Taub
Mike Pearson’s New Prescription for the Pharmaceuticals Industry
Michael Peltz
The Morning Brief: Alcoa Trades Expanded Board for Elliott’s Support
Stephen Taub
The Morning Brief: At SALT— Heat, Light and a Few Ideas
Stephen Taub
The Morning Brief: Cooperman on Netflix, First Data and Fees
Stephen Taub
The Morning Brief: Managed Futures Funds Weather Turbulence in April
Stephen Taub
The Morning Brief: Marcato’s McGuire Exits NCR Board
Stephen Taub
The Morning Brief: Pershing Square Plans Conference Call on Valeant
Stephen Taub
The Morning Brief: Valeant Slips as Investors Bail
Stephen Taub
More Articles